These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1533584

  • 1. Selected aspects of polycystic ovarian disease.
    Goldzieher JW, Young RL.
    Endocrinol Metab Clin North Am; 1992 Mar; 21(1):141-71. PubMed ID: 1533584
    [Abstract] [Full Text] [Related]

  • 2. Polycystic ovarian disease.
    Raj SG, Talbert LM.
    Obstet Gynecol Annu; 1984 Mar; 13():261-73. PubMed ID: 6232474
    [Abstract] [Full Text] [Related]

  • 3. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE, Anania C, Malinak R.
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [Abstract] [Full Text] [Related]

  • 4. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S, Adams J, Mason H, Polson D.
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [Abstract] [Full Text] [Related]

  • 5. Resistant cases of polycystic ovarian disease successfully treated with a combination of corticosteroids, clomiphene, and bromocriptine.
    Homburg R, Ashkenazi J, Goldman J.
    Int J Fertil; 1988 Sep; 33(6):393-7. PubMed ID: 2906913
    [Abstract] [Full Text] [Related]

  • 6. Induction of ovulation in the patient with polycystic ovarian disease.
    Blankstein J, Quigley MM.
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):733-49. PubMed ID: 3143566
    [Abstract] [Full Text] [Related]

  • 7. Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.
    Seibel MM, Oskowitz S, Kamrava M, Taymor ML.
    Obstet Gynecol; 1984 Aug; 64(2):213-9. PubMed ID: 6234484
    [Abstract] [Full Text] [Related]

  • 8. Modern management of secondary amenorrhoea.
    Banerjee S.
    Calcutta Med J; 1989 Aug; 86(5-6):46-9. PubMed ID: 12284231
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O, Yalcinoglu AI, Kafkasli A, Burak F, Ozekici U.
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [Abstract] [Full Text] [Related]

  • 10. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
    Fertil Steril; 2008 Mar; 89(3):505-22. PubMed ID: 18243179
    [Abstract] [Full Text] [Related]

  • 11. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
    Saffan DS, Seibel MM.
    J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
    [Abstract] [Full Text] [Related]

  • 12. Surgical treatment in polycystic ovary syndrome.
    Unlu C, Atabekoglu CS.
    Curr Opin Obstet Gynecol; 2006 Jun; 18(3):286-92. PubMed ID: 16735828
    [Abstract] [Full Text] [Related]

  • 13. Endoscopic carbon dioxide laser ovarian wedge resection in resistant polycystic ovarian disease.
    Ostrzenski A.
    Int J Fertil; 1992 Jun; 37(5):295-9. PubMed ID: 1358842
    [Abstract] [Full Text] [Related]

  • 14. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V, Barash A, Shoham Z, Koistinen R, Seppala M, Hen M, Lunenfeld B, Zadik Z.
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [Abstract] [Full Text] [Related]

  • 15. Steroidogenesis in human polycystic ovary.
    Mahajan DK.
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):751-69. PubMed ID: 3143567
    [Abstract] [Full Text] [Related]

  • 16. Evaluation and therapy of polycystic ovarian syndrome.
    Loy R, Seibel MM.
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):785-813. PubMed ID: 3143568
    [Abstract] [Full Text] [Related]

  • 17. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
    Burger CW, Korsen TJ, Hompes PG, van Kessel H, Schoemaker J.
    Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
    [Abstract] [Full Text] [Related]

  • 18. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME, Alborzi S, Jahromi BN.
    Int J Fertil Womens Med; 2002 Dec; 47(6):272-7. PubMed ID: 12570169
    [Abstract] [Full Text] [Related]

  • 19. [Advance in treatment of polycystic ovary syndrome].
    Krysiak R, Okopień B, Herman ZS.
    Pol Merkur Lekarski; 2005 Dec; 19(114):848-54. PubMed ID: 16521439
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.